Savara (SVRA) Secures $5M Award from Cystic Fibrosis Foundation Therapeutics Inc. for Development of AeroVanc Street Insider By John Harbison|2017-11-29T16:55:53-08:00November 29, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara (SVRA) Secures $5M Award from Cystic Fibrosis Foundation Therapeutics Inc. for Development of AeroVanc Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
